Profile for Australia Patent: 2011293502
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2011293502
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | May 31, 2033 | Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate |
| ⤷ Start Trial | Aug 23, 2031 | Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate |
| ⤷ Start Trial | Aug 23, 2031 | Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate |
| ⤷ Start Trial | Aug 23, 2031 | Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate |
| ⤷ Start Trial | Aug 23, 2031 | Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
